Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-19 23:49 | 2022-09-15 | ATRC | AtriCure, Inc. | Doraiswamy Vinayak | Officer | SELL | $45.99 | 4,983 | $229,168 | 19,406 |
| 2022-09-20 00:23 | 2022-09-15 | LUNG | Pulmonx Corp | French Glendon E. III | Director, Officer | SELL | $20.00 | 25,000 | $500,000 | 1,027,944 |
| 2022-09-16 23:36 | 2022-09-15 | BSX | BOSTON SCIENTIFIC CORP | Carruthers Wendy | Officer | SELL | $42.21 | 7,500 | $316,586 | 109,913 |
| 2022-09-17 00:47 | 2022-09-15 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% owner | BUY | $8.09 | 6,530 | $52,853 | 121,247 |
| 2022-09-17 02:18 | 2022-09-15 | RMD | RESMED INC | Douglas Robert Andrew | Officer | OPT+S | $232.47 | 17,189 | $3,995,863 | 228,995 |
| 2022-09-17 04:00 | 2022-09-14 | TMCI | TREACE MEDICAL CONCEPTS, INC. | TREACE JAMES T | Director | SELL | $23.03 | 50,000 | $1,151,415 | 1,136,441 |
| 2022-09-15 23:05 | 2022-08-16 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% owner | BUY | $8.10 | 5,221 | $42,285 | 120,217 |
| 2022-09-15 16:12 | 2022-09-13 | SRTS | Sensus Healthcare, Inc. | Sardano Michael | Officer | OPT+S | $14.13 | 5,000 | $70,628 | 49,519 |
| 2022-09-16 01:00 | 2022-09-13 | TMCI | TREACE MEDICAL CONCEPTS, INC. | BAYS F BARRY | Director | SELL | $23.22 | 68,357 | $1,587,113 | 1,648,072 |
| 2022-09-14 21:16 | 2022-09-12 | IRTC | iRhythm Holdings, Inc. | Bairey Merz Cathleen Noel | Director | SELL | $159.77 | 90 | $14,379 | 4,887 |
| 2022-09-15 03:17 | 2022-09-12 | MDXG | MIMEDX GROUP, INC. | Stein Robert Benjamin | Officer | SELL | $3.44 | 27,329 | $94,069 | 278,673 |
| 2022-09-13 23:15 | 2022-09-08 | NVCR | NovoCure Ltd | Leonard Frank X | Officer | SELL | $81.48 | 6,754 | $550,316 | 77,396 |
| 2022-09-13 23:24 | 2022-09-12 | VERO | Venus Concept Inc. | Georgiadis Anna | Officer | BUY | $0.71 | 12,782 | $9,083 | 12,782 |
| 2022-09-12 23:32 | 2022-09-09 | NVCR | NovoCure Ltd | Leonard Frank X | Officer | SELL | $88.00 | 1,863 | $163,944 | 84,150 |
| 2022-09-13 02:56 | 2022-09-08 | INFU | InfuSystem Holdings, Inc | Lehman Gregg Owen | Director | OPT+S | $7.79 | 15,257 | $118,818 | 346 |
| 2022-09-12 15:00 | 2022-09-08 | CTSO | Cytosorbents Corp | Chan Phillip P. | Director, Officer | BUY | $1.70 | 35,000 | $59,500 | 867,279 |
| 2022-09-10 02:32 | 2022-09-07 | PEN | Penumbra Inc | Roberts Johanna | Officer | OPT+S | $175.17 | 5,800 | $1,015,986 | 55,496 |
| 2022-09-09 02:41 | 2022-09-06 | INFU | InfuSystem Holdings, Inc | Whitman Kevin | Officer | OPT+S | $7.65 | 2,642 | $20,211 | 4,341 |
| 2022-09-07 23:41 | 2022-09-06 | HAE | HAEMONETICS CORP | Llorens Josep | Officer | SELL | $73.78 | 101 | $7,452 | 17,234 |
| 2022-09-07 20:37 | 2022-09-02 | STSS | Sharps Technology Inc. | Hayes Robert Michael | Director, Officer | BUY | $1.35 | 5,000 | $6,769 | 53,082 |
| 2022-09-07 20:40 | 2022-08-26 | BJDX | Bluejay Diagnostics, Inc. | Fisher Kenneth R | Officer | BUY | $1.03 | 20,000 | $20,600 | 40,000 |
| 2022-09-07 23:27 | 2022-09-06 | NVCR | NovoCure Ltd | Leonard Frank X | Officer | SELL | $78.57 | 1,384 | $108,741 | 86,013 |
| 2022-09-07 23:32 | 2022-09-06 | BSX | BOSTON SCIENTIFIC CORP | Mahoney Michael F | Director, Officer | OPT+S | $40.49 | 125,828 | $5,094,310 | 1,767,665 |
| 2022-09-07 23:41 | 2022-09-02 | SRTS | Sensus Healthcare, Inc. | Sardano Joseph C | Director, Officer | SELL | $12.53 | 41,588 | $521,256 | 1,130,293 |
| 2022-09-07 23:54 | 2022-09-06 | RMD | RESMED INC | PENDARVIS DAVID | Officer | SELL | $216.92 | 1,545 | $335,141 | 105,424 |
| 2022-09-07 00:16 | 2022-09-02 | NVCR | NovoCure Ltd | Burke William Patrick | Officer | SELL | $79.04 | 718 | $56,749 | 55,486 |
| 2022-09-07 00:15 | 2022-09-02 | NVCR | NovoCure Ltd | Cordova Ashley | Officer | SELL | $79.04 | 885 | $69,948 | 72,376 |
| 2022-09-07 00:12 | 2022-09-02 | NVCR | NovoCure Ltd | Shah Pritesh | Officer | SELL | $79.04 | 269 | $21,261 | 83,230 |
| 2022-09-06 23:19 | 2022-09-01 | NVCR | NovoCure Ltd | Leonard Frank X | Officer | SELL | $77.50 | 14,796 | $1,146,634 | 87,397 |
| 2022-09-07 01:39 | 2022-09-01 | INFU | InfuSystem Holdings, Inc | RUIZ THOMAS MARK | Officer | OPT+S | $7.60 | 10,000 | $75,950 | 32,893 |
| 2022-09-07 00:14 | 2022-09-02 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Officer | SELL | $79.04 | 296 | $23,395 | 165,024 |
| 2022-09-06 23:53 | 2022-09-01 | LUNG | Pulmonx Corp | Sung Derrick | Officer | SELL | $17.87 | 1,082 | $19,335 | 253,815 |
| 2022-09-06 23:52 | 2022-09-01 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Officer | SELL | $17.89 | 1,027 | $18,372 | 182,092 |
| 2022-09-06 23:51 | 2022-09-01 | LUNG | Pulmonx Corp | Lehman David Aaron | Officer | SELL | $17.88 | 1,082 | $19,350 | 45,229 |
| 2022-09-06 23:50 | 2022-09-01 | LUNG | Pulmonx Corp | French Glendon E. III | Director, Officer | SELL | $17.87 | 2,940 | $52,538 | 1,052,944 |
| 2022-09-06 16:33 | 2022-09-01 | DXCM | DEXCOM INC | Dolan Matthew Vincent | Officer | SELL | $81.63 | 5 | $408 | 26,536 |
| 2022-09-03 03:00 | 2022-09-01 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Owens Daniel E. | Officer | OPT+S | $19.82 | 2,500 | $49,562 | 10,700 |
| 2022-09-02 19:28 | 2022-08-31 | ATAO | Premier Air Charter Holdings Inc. | Fourth Street Fund, LP | SELL | $0.02 | 2,500,000 | $50,000 | 141,793,050 | |
| 2022-09-02 23:35 | 2022-09-01 | ARAY | Accuray Incorporated | Pervaiz Ali | Officer | SELL | $2.38 | 8,069 | $19,204 | 187,523 |
| 2022-09-02 23:35 | 2022-09-01 | ARAY | Accuray Incorporated | Green Brandon W | Officer | SELL | $2.38 | 10,374 | $24,690 | 174,462 |
| 2022-09-01 18:48 | 2022-08-30 | STSS | Sharps Technology Inc. | Hayes Robert Michael | Director, Officer | BUY | $1.35 | 8,073 | $10,867 | 48,082 |
| 2022-09-02 00:21 | 2022-09-01 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Treace John T. | Director, Officer, 10% owner | BUY | $19.80 | 10,000 | $198,031 | 5,516,455 |
| 2022-08-31 23:51 | 2022-08-29 | APYX | Apyx Medical Corporation | Goodwin Charles D. II | Director, Officer | BUY | $5.96 | 11,750 | $70,068 | 40,000 |
| 2022-08-31 16:00 | 2022-08-30 | NXGL | NEXGEL, INC. | Spinrad Yaakov | Director | BUY | $1.68 | 1,648 | $2,769 | 1,648 |
| 2022-09-01 02:03 | 2022-08-30 | VERO | Venus Concept Inc. | Serafino Domenic | Director, Officer | BUY | $0.33 | 75,000 | $25,020 | 1,008,758 |
| 2022-08-31 16:00 | 2022-08-30 | NXGL | NEXGEL, INC. | STEFANSKY DAVID | Director | BUY | $1.66 | 5,000 | $8,280 | 27,591 |
| 2022-09-01 00:52 | 2022-08-29 | TMCI | TREACE MEDICAL CONCEPTS, INC. | BAYS F BARRY | Director | SELL | $20.11 | 11,864 | $238,636 | 1,716,429 |
| 2022-08-31 15:42 | 2022-08-25 | OSUR | ORASURE TECHNOLOGIES INC | Aspinall Mara G. | Director | BUY | $4.19 | 6,000 | $25,138 | 77,218 |
| 2022-08-30 17:03 | 2022-08-26 | STSS | Sharps Technology Inc. | Hayes Robert Michael | Director, Officer | BUY | $1.41 | 4,009 | $5,662 | 40,009 |
| 2022-08-31 01:09 | 2022-08-29 | UFPT | UFP TECHNOLOGIES INC | Litterio Christopher P. | Officer | OPT+S | $95.90 | 5,500 | $527,450 | 14,624 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.